Dachaigh › Aillse a' bhroilleach › Kansas

Sgrùdaidhean clionaigeach Aillse a' bhroilleach ann an Kansas

Tha 26 sgrùdaidhean airson Aillse a' bhroilleach a’ lorg phàirtichean aig làraichean ann an Kansas.

Bailtean ann an Kansas

Teacsa sgrùdaidh oifigeil (Beurla)

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Central Care Cancer Center - Garden City, Garden City
Central Care Cancer Center - Great Bend, Great Bend
Veteran Administration Eastern Kansas Healthcare, Leavenworth
agus 4 a bharrachd

A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain

Aoisean 40 gu 75 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT05334069

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

The University of Kansas Cancer Center, Westwood

A’ fastadhÌre 3

Aoisean 60 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06377852

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Cancer Center of Kansas, Wichita

A’ fastadhÌre 3

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT06492616

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

University of Kansas Hospital-Cancer Center, Fairway

A’ fastadhÌre 1/2

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Sult 2026 · NCT07287917

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

University of Kansas Cancer Center, Westwood
Cancer Center of Kansas, Wichita

A’ fastadhÌre 3

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT06982521

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Central Care Cancer Center - Garden City, Garden City
Central Care Cancer Center - Great Bend, Great Bend
HaysMed, Hays
agus 10 a bharrachd

A’ fastadhÌre 3

Aoisean 18 gu 60 · Banairean · Air ùrachadh 2 Sult 2026 · NCT05879926

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

AMR Kansas City Oncology, Kansas City

A’ fastadhÌre 3

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Sult 2026 · NCT06072612

Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry

Hays Medical Center Dreiling-Schmidt Cancer Institute, Hays
KCCC West, Kansas City
KCCC Overland Park, Overland Park
agus 3 a bharrachd

A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain

Gach aois · Gach gnè · Air ùrachadh 18 Lùna 2026 · NCT02302742

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

University of Kansas Cancer Center, Kansas City
University of Kansas Cancer Center-Overland Park, Overland Park

A’ fastadhÌre 3

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Lùna 2026 · NCT06500481

Sequencing Antibody Drug Conjugates in ER+/HER2 LOW/ULTRA LOW MBC

University of Kansas Medical Center, Fairway

A’ fastadhÌre 2

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 12 Lùna 2026 · NCT06263543

Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction

University of Kansas Cancer Center, Kansas City

A’ fastadhÌre 2Fàilte do shaor-thoilich fhallain

Aoisean 45 gu 74 · Banairean · Air ùrachadh 4 Lùna 2026 · NCT06195306

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

University of Kansas Medical Center (KUMC), Westwood

A’ fastadhÌre 1/2

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Lùna 2026 · NCT05579366

E-Mindfulness Approaches for Living After Breast Cancer

Cotton O'Neil Cancer Center / Stormont Vail Health, Topeka

A’ fastadhÌre 3

Aoisean 18 gu 50 · Gach gnè · Air ùrachadh 4 Lùna 2026 · NCT06748222

Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial

University of Kansas Cancer Center, Kansas City

A’ fastadhÌre 2

Aoisean 18 gu 55 · Banairean · Air ùrachadh 27 Iuch 2026 · NCT06184750

HER2-positive Breast Cancer Registry

The University of Kansas Cancer Center, Westwood

A’ fastadhSgrùdadh amharc

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Iuch 2026 · NCT06603597

Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer

University of Kansas Cancer Center, Kansas City

A’ fastadhÌre 2

Aoisean 35 agus nas sine · Banairean · Air ùrachadh 7 Iuch 2026 · NCT05941520

Integrated Cancer Repository for Cancer Research

Saint Luke's Cancer Instititute - South, Overland Park

A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain

Aoisean 19 gu 110 · Gach gnè · Air ùrachadh 29 Ògmh 2026 · NCT02012699

Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)

The University of Kansas Cancer Center, Westwood

A’ fastadhÌre 3

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Cèit 2026 · NCT06757634

Trial of Neoadjuvant THP vs TCHP for HER2-Amplified/Positive Breast Cancer

The University of Kansas Cancer Center (KUCC), Fairway
The University of Kansas Cancer Center - Westwood, Kansas City
KUCC - Indian Creek, Overland Park
agus 3 a bharrachd

A’ fastadhÌre 2

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 6 Cèit 2026 · NCT07220135

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

University of Kansas Cancer Center, Kansas City
The University of Kansas Cancer Center - Olathe, Olathe
University of Kansas Cancer Center-Overland Park, Overland Park
agus 8 a bharrachd

A’ fastadhÌre 3

Aoisean 50 gu 70 · Gach gnè · Air ùrachadh 23 Gibl 2026 · NCT04852887

Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis

The University of Kansas Cancer Center, Westwood

A’ fastadhÌre 1/2

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 20 Gibl 2026 · NCT06374459

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

HaysMed, Hays
Lawrence Memorial Hospital, Lawrence
The University of Kansas Cancer Center - Olathe, Olathe
agus 6 a bharrachd

A’ fastadhSgrùdadh amharc

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Màrt 2026 · NCT06418204

EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

University of Kansas Cancer Center, Westwood

A’ fastadhSgrùdadh amharc

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 20 Faoi 2026 · NCT06401421

Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer

Cancer Center of Kansas, Wichita

A’ fastadhÌre 2

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Samh 2025 · NCT04553770

High Risk Breast Clinic: Protocol for Women at Increased Risk for Developing Breast Cancer

University of Kansas Medical Center, Kansas City

A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain

Aoisean 30 gu 65 · Banairean · Air ùrachadh 29 Dàmh 2025 · NCT00291096

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

HaysMed University of Kansas Health System, Hays
University of Kansas Cancer Center-West, Kansas City
University of Kansas Cancer Center, Kansas City
agus 5 a bharrachd

A’ fastadhÌre 3

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 8 Dàmh 2025 · NCT03418961

Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.